Mono Pharmacare Balance Sheet Health
Financial Health criteria checks 2/6
Mono Pharmacare has a total shareholder equity of ₹275.5M and total debt of ₹381.8M, which brings its debt-to-equity ratio to 138.6%. Its total assets and total liabilities are ₹752.8M and ₹477.3M respectively. Mono Pharmacare's EBIT is ₹50.9M making its interest coverage ratio 2.6. It has cash and short-term investments of ₹27.1M.
Key information
138.6%
Debt to equity ratio
₹381.83m
Debt
Interest coverage ratio | 2.6x |
Cash | ₹27.09m |
Equity | ₹275.53m |
Total liabilities | ₹477.27m |
Total assets | ₹752.79m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MONOPHARMA's short term assets (₹743.3M) exceed its short term liabilities (₹299.2M).
Long Term Liabilities: MONOPHARMA's short term assets (₹743.3M) exceed its long term liabilities (₹178.0M).
Debt to Equity History and Analysis
Debt Level: MONOPHARMA's net debt to equity ratio (128.7%) is considered high.
Reducing Debt: Insufficient data to determine if MONOPHARMA's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: MONOPHARMA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: MONOPHARMA's interest payments on its debt are not well covered by EBIT (2.6x coverage).